The Cabinet of St. Vincent and the Grenadines has given the green light for the start of operations of the first cannabis pharmacy here.
A release from the Medicinal Cannabis Authority, MCA, says this follows approval of the first cannabis dispensing licence.
This means that the company can now procure and dispense medicinal cannabis products legally in the country. The Company, Green Lava (SVG) Inc., was among the first entities to receive the approval of Cabinet for a medicinal cannabis licence on July 10, 2019.
After making the requisite investments to implement the stipulated security and operational requirements, Green Lava officially launched operations on November 15, 2019. The Company currently has a staff compliment of over 20 persons, who are involved in medicinal cannabis production at its 5-acre farm in Queensbury, Vermont.
The MCA says, with the gazetting of the Patient Access to Medicinal Cannabis Regulations by the Government on May 6, 2020, Green Lava will now further roll-out its business model with the establishment of a pharmacy to provide medicinal cannabis products to persons with qualifying medical conditions.
The first step involved an application for a Retail Pharmacy Permit, which received approval from the SVG Pharmacy Council on July 28, 2020. Pursuant to the Medicinal Cannabis Industry Act and its regulations, an application was then submitted to the Medicinal Cannabis Authority for a dispensing licence. Cabinet subsequently approved the granting of this licence on August 10, 2020. Green Lava has signed agreements with two local traditional cultivator’s groups to procure raw cannabis product from their farm to make available in its dispensary.
There are twenty ‘qualifying medical conditions’ through which patients can access medicinal cannabis in St Vincent and the Grenadines, under the Medicinal Cannabis Industry Act 2018.
These include, pain associated with cancer, severe and treatment-resistant nausea and vomiting due to chemotherapy, Parkinson’s disease, multiple sclerosis, glaucoma, sickle cell anaemia, anxiety, sleep disorders and chronic pain. There is also provision for any other illness or condition to be incorporated as a qualifying medical condition upon declaration by the Minister, acting on the advice of the Medicinal Cannabis Advisory Council.